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Tryptophan Fluorescence Reveals the Conformational State of a Dynamic
Loop in Recombinant Porcine Fructose-1,6-bisphosphatase
Abstract
Wild-type porcine fructose-1,6-bisphosphatase (FBPase) has no tryptophan residues. Hence, the mutation of
Try57 to tryptophan places a unique fluorescent probe in the structural element (loop 52−72) putatively
responsible for allosteric regulation of catalysis. On the basis of steady-state kinetics, circular dichroism
spectroscopy, and X-ray crystallography, the mutation has little effect on the functional and structural
properties of the enzyme. Fluorescence intensity from the Trp57 mutant is maximal in the presence of
divalent cations, fructose 6-phosphate and orthophosphate, which together stabilize an R-state conformation
in which loop 52−72 is engaged with the active site. The level of fluorescence emission decreases
monotonically with increasing levels of AMP, an allosteric inhibitor, which promotes the T-state, disengaged-
loop conformation. The titration of various metal−product complexes of the Trp57 mutant with fructose
2,6-bisphosphate (F26P2) causes similar decreases in fluorescence, suggesting that F26P2 and AMP
individually induce similar conformational states in FBPase. Fluorescence spectra, however, are sensitive to
the type of divalent cation (Zn2+, Mn2+, or Mg2+) and suggest conformations in addition to the R-state,
loop-engaged and T-state, loop-disengaged forms of FBPase. The work presented here demonstrates the utility
of fluorescence spectroscopy in probing the conformational dynamics of FBPase.
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ABSTRACT: Wild-type porcine fructose-1,6-bisphosphatase (FBPase) has no tryptophan residues. Hence,
the mutation of Try57 to tryptophan places a unique fluorescent probe in the structural element (loop
52-72) putatively responsible for allosteric regulation of catalysis. On the basis of steady-state kinetics,
circular dichroism spectroscopy, and X-ray crystallography, the mutation has little effect on the functional
and structural properties of the enzyme. Fluorescence intensity from the Trp57 mutant is maximal in the
presence of divalent cations, fructose 6-phosphate and orthophosphate, which together stabilize an R-state
conformation in which loop 52-72 is engaged with the active site. The level of fluorescence emission
decreases monotonically with increasing levels of AMP, an allosteric inhibitor, which promotes the T-state,
disengaged-loop conformation. The titration of various metal-product complexes of the Trp57 mutant
with fructose 2,6-bisphosphate (F26P2) causes similar decreases in fluorescence, suggesting that F26P2
and AMP individually induce similar conformational states in FBPase. Fluorescence spectra, however,
are sensitive to the type of divalent cation (Zn2+, Mn2+, or Mg2+) and suggest conformations in addition
to the R-state, loop-engaged and T-state, loop-disengaged forms of FBPase. The work presented here
demonstrates the utility of fluorescence spectroscopy in probing the conformational dynamics of FBPase.
Fructose-1,6-bisphosphatase [D-fructose-1,6-bisphosphate
1-phosphohydrolase, EC 3.1.3.11 (FBPase1)] catalyzes the
hydrolysis of fructose 1,6-bisphosphate (F16P2) to fructose
6-phosphate (F6P) and inorganic phosphate (Pi) (1, 2).
FBPase, along with fructose-6-phosphate 1-kinase, defines
a futile cycle in the gluconeogenic/glycolytic pathways.
Hence, FBPase activity is regulated tightly, being inhibited
by F26P2 and AMP (3-5). The kinetic mechanism of AMP
inhibition is nonlinear and noncompetitive with respect to
F16P2 and nonlinear and competitive with respect to Mg2+
(6, 7). FBPase requires divalent cations (Mg2+, Mn2+, or
Zn2+), and rates of reaction vary sigmoidally with metal ion
concentration (Hill coefficient of 2) (8-10). AMP binds to
allosteric sites, which are 28 Å from the nearest active site
(11). F26P2 exhibits competitive inhibition kinetics with
respect to F16P2, and binds to the active site as a substrate
analogue. AMP and F26P2 inhibit FBPase synergistically (3-
5). Indeed, the koff for AMP decreases in the presence of
F26P2 (12).
FBPase is a homotetramer [subunit with an Mr of 37 000
(13)], which exists in at least two conformational states called
R and T (14, 15). AMP, with or without F26P2, stabilizes
the inactive T-state (16-18). The active R-state is favored
by substrates or products in combination with metal cations
(14, 19). Directed mutations implicate loop 52-72 in the
allosteric regulation of FBPase (20, 21). Product complexes
with FBPase in the presence of Mg2+ and Zn2+ reveal an
ordered loop, closely associated with the active site. Product
complexes with AMP, on the other hand, reveal a disordered
loop, and all but one metal cation displaced from the active
site (22). A mechanism for allosteric regulation of catalysis
in FBPase, proposed by Choe et al. (19), involves two
conformational states of loop 52-72 (called engaged and
disengaged). AMP and, presumably, F26P2 stabilize a
disengaged loop, whereas metal cations stabilize an engaged
loop.
Although crystallographic studies provide rich detail, they
are difficult to perform over a broad range of experimental
conditions. Furthermore, the process of crystallization selects
typically only one family of closely related conformers from
what might be a diverse population of conformers in solution.
Hence, to complement X-ray diffraction studies, and provide
information regarding FBPase conformers over a variety of
experimental conditions, we have introduced a spectroscopic
probe into loop 52-72. As porcine FBPase has no tryptophan
residues, a directed mutation can easily introduce a unique
fluorophore. Tyr57 of loop 52-72 is an attractive target for
tryptophan substitution. Tyr57 has a large side chain, which
exists in different environments in the engaged and disen-
gaged conformation of loop 52-72. Reported here are the
kinetic and structural properties of the Trp57 mutant of
FBPase, and its conformational response, as assessed by
† This work was supported in part by National Institutes of Health
Research Grant NS 10546 and National Science Foundation Grant
MCB-9603595. This is journal paper 18896 from the Iowa Agriculture
and Home Economic Experiment Station, Ames, IA, Project 3191, and
is supported by Hatch Act and State of Iowa funds.
‡ The atomic coordinates and structure factors (codes 1FJ6 and 1FJ9)
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for Structural Bioinformatics (RCSB).
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steady-state fluorescence spectroscopy, to a variety of metal
cations and physiologically relevant ligands
EXPERIMENTAL PROCEDURES
Materials. F16P2, F26P2, NADP+, AMP, ampicillin, and
IPTG were purchased from Sigma. DNA-modifying and
restriction enzymes, T4 polynucleotide kinase, and ligase
were from Promega. Glucose-6-phophate dehydrogenase and
phosphoglucose isomerase were from Roche. Tryptone, yeast
extract, and agar were from Difco. Other chemicals were
reagent grade or the equivalent. Escherichia coli strains BMH
71-18 mutS and XL1-Blue came from Clontech and Stragene,
respectively. FBPase-deficient strain DF 657 was from the
Genetic Stock Center at Yale University.
Mutagenesis of FBPase. The mutation was introduced by
changing specific bases in the double-stranded plasmid using
the Transformer site-directed mutagenesis kit (23). The
primer for the Tyr57 f Trp mutation was 5′-CGCAC-
CTCTGGGGAATGG-3′ (codon for tryptophan underlined
in boldface). The selection primer, 5′-CAGCCTCGCCTC-
GAGAACGCCA-3′ (digestion site underlined in boldface),
changed an original NruI to a XhoI site on the plasmid.
Unanticipated mutations were ruled out by sequencing the
entire gene, after which the mutant plasmid was used in the
transformation of E. coli DE 657 (DE3) cells. The Iowa State
University sequencing facility provided DNA sequences,
using the fluorescent dye dideoxy terminator method.
Expression and Purification of Wild-Type and Mutant
FBPases. Expression and purification of FBPase were
performed as previously described (24) with minor alter-
ations. After cell breakage, the enzyme was concentrated by
adding enough ammonium sulfate to produce a 70% saturated
solution. The precipitate was then taken up in 20 mM Tris
(pH 7.5) and desalted on a G-100 Sephadex column using
the resuspension buffer. Fractions with FBPase activity were
loaded onto a Cibacron Blue column and eluted with a NaCl
gradient (0.5-1 M). FBPase appeared at approximately 0.8
M NaCl. The eluent was then dialyzed against 20 mM Tris-
HCl (pH 8.3) and loaded onto a DEAE-Sephadex column
and eluted with a NaCl gradient (from 0 to 0.3 M). FBPase
appeared at a salt concentration of 0.15 M. The protein purity
was determined by SDS-PAGE (12% gel) (25). The protein
concentration was determined by the method of Bradford
(26), using bovine serum albumin as a standard.
Kinetic Experiments. All assays employed the coupling
of phosphoglucose isomerase and glucose-6-phosphate de-
hydrogenase (1). The specific activity, kcat, and pH 7.5/pH
9.5 activity ratios were determined by directly monitoring
the reduction of NADP+ to NADPH at 340 nm. All other
kinetic experiments monitored the fluorescence emission
from NADPH at 470 nm, using an excitation wavelength of
340 nm (7). Initial rate data were analyzed using programs
written either in MINITAB (25) or by ENZFITTER (26).
Circular Dichroism (CD) Spectroscopy. Spectra were
recorded from 200 to 260 nm in steps of 1.3 nm on a Jasco
J710 spectrometer in a 1 mm cell at room temperature using
a protein concentration of approximately 0.25 mg/mL.
Spectra were recorded in 20 mM Tris (pH 7.5) and with 20
mM Tris, 5 mM Mg2+, 5 mM KPi, and 5 mM F6P, with and
without AMP (400 íM) or F26P2 (240 íM). Each spectrum
was blank-corrected and smoothed using the software
provided with the instrument.
Crystallization of the Trp57 Mutant. Crystals of both T-
and R-state product complexes grew from hanging drops with
a total volume of 4 íL. T-State crystals grew from equal
volumes of a protein solution [10 mg/mL Trp57 mutant, 100
mM Hepes (pH 7), 2 mM ZnCl2, 5 mM F6P, 10 mM KPi
(pH 7), and 5 mM AMP] and a precipitant solution [100
mM Hepes (pH 7) and polyethylene glycol 3350 (17% w/v)].
R-State crystals grew from equal volumes of a protein
solution, as above only without AMP, and a precipitant
solution [100 mM Hepes (pH 7) and polyethylene glycol
3350 (6% w/v)]. Wells contained 500 íL of the precipitant
solution. Crystals grew in approximately 2 days at 37 °C.
Data Collection. Data were collected from one T-state
crystal (dimensions of 0.3 mm  0.2 mm  0.3 mm) and
one R-state crystal (dimensions of 0.3 mm  0.3 mm  0.4
mm) at Iowa State University on a rotating anode/Siemens
X-1000 area detector at 120 K, using Cu KR radiation passed
through a graphite monochromator. Data were reduced by
XENGEN (29).
Model Refinement. Initial phases were calculated from the
Zn2+-product complex of wild-type FBPase (18) for the
R-state structure and from the AMP-Zn2+-product complex
(22) for the T-state structure. Refinement employed XPLOR
(30) as described previously (19). Constants of force and
geometry for the protein came from Engh and Huber (31).
In early rounds of refinement, models were heated to 2000
K and then cooled to 300 K in steps of 25 K. In later rounds
of refinement, the systems were heated to 1000 K and cooled
in steps of 10 K. After the slow cooling protocol was
complete, the models were exposed to 120 steps of conju-
gated gradient minimization, followed by 20 steps of
individual B-parameter refinement. Individual B-parameters
were subject to the following restraints: nearest neighbor,
main chain atoms, 1.5 Å2; next-to-nearest neighbor, side
chain atoms, 2.0 Å2; nearest neighbor, side chain atoms, 2.0
Å2; and next-to-nearest neighbor, side chain atoms, 2.5 Å2.
Water molecules were fit to difference electron density of
2.5ó or better and were added until no significant decrease
was evident in Rfree. For comparison of the mutant and wild-
type structures, we employed programs from the CCp4 suite
of programs (32).
Steady-State Fluorescence Measurements. Fluorescence
data were collected using a SLM 8100C fluorimeter from
Spectronic Instruments. To avoid exciting tyrosyl side chains,
an excitation wavelength of 295 nm was used. Emission
spectra were recorded in steps of 2 nm from 310 to 400 nm,
using a slit width of 2 mm. Enzyme concentrations were
from 0.2 to 0.5 íM. Each spectrum was an average of five
to seven scans. Ligands were added to a solution of
tryptophan (100 íM), to ascertain whether they alone
influenced the fluorescence emission from tryptophan. Blanks
were subtracted from all spectra, and corrections for protein
dilutions were made. Conditions under which specific spectra
were recorded are provided in the text, tables, and figure
legends.
AMP titration data were analyzed by nonlinear least-
squares fits, using the following equation:
¢F
Fo
)
(¢Fmax/Fo)Ln
Kd + L
n
(1)
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where ¢F is the change in fluorescence caused upon addition
of ligand L, Fo is the fluorescence in the absence of ligand,
Kd is the dissociation constant, and n is the Hill coefficient.
RESULTS
Kinetic Properties of Wild-Type FBPase and the Tyr57
f Trp Mutant. Wild-type and mutant proteins behave
identically in chromatographic separations and are at least
95% pure, as determined by SDS-PAGE. The ratio of
catalytic rates at pH 7.5 to 9.5 indicates an intact (nonpro-
teolyzed) FBPase. The mutation of Tyr57 to tryptophan does
not affect kinetic parameters significantly (Table 1). The Ki
values for inhibition by AMP and F26P2 increase 5- and
4-fold, respectively, relative to that of wild-type FBPase.
Other mutations of loop 52-72 cause increases in Ki values
for AMP and F26P2 (20, 21) and, along with the Trp57
mutant described here, may simply reflect the well-
documented binding synergism of these ligands (6-8). Data
from initial rate assays indicate no change in the mechanisms
of inhibition by AMP and F26P2.
Secondary Structure Analysis. The CD spectra of wild-
type and Trp57 FBPases are identical from 200 to 260 nm
(data not shown). CD spectra for the Trp57 mutant change
in response to AMP, as noted in previous work on the wild-
type enzyme (15). The Trp57 mutant also responds to the
addition of F26P2, yielding a CD spectrum that is identical
to that observed in the presence of AMP.
Crystal Structures of R-State and T-State Trp57 FBPase.
Crystals of the Trp57 mutant grown in the presence of Zn2+
and products (F6P and Pi) belong to space group I222 (a )
51.57 Å, b ) 82.47 Å, and c ) 165.57 Å) and are
isomorphous with respect to the R-state, Zn2+-product
complex of the wild-type enzyme (19). Similarly, crystals
of the Trp57 mutant grown in the presence of Zn2+, products,
and AMP belong to space group P21212 (a ) 59.82 Å, b )
165.48 Å, and c ) 79.29 Å) and are isomorphous with
respect to the T-state, Zn2+-product-AMP complex of the
wild-type enzyme (22). Statistics for data collection and
refinement for both crystal forms are in Table 2. The
stereochemistry of the models is generally very good as
determined by PROCHECK (33). The method of Luzzati
(34) indicates an uncertainty in coordinates of approximately
0.3 Å for both structures.
Residues 22-27, 142, and 143 are in weak electron density
and have high thermal parameters in the R-state complex.
The root-mean-square deviation between CR atoms of the
Trp57 mutant and wild-type FBPases is 0.28 Å for the entire
model and 0.2 Å for loop 52-72. Deviations of up to 1.6 Å
are in regions of weak electron density, as noted above.
Distinct and strong electron density covers Trp57 and
residues in its vicinity (Figure 1). The indole moiety of Trp57
occupies the same pocket as the side chain of Tyr57 of the
wild-type enzyme, and is in contact with Ala51, Gly52,
Leu126, Leu129, and Asp127 of its own subunit and Val196,
Met172, and Met185 from the adjacent subunit (C1-C2
interface).
Residues 55-70, 142, 143, and 267-269 are in weak
electron density in the T-state complex. Indeed, although
residues 63-70 are part of the model, they are associated
with electron density no higher than the noise level of the
map. The root-mean-square deviation between CR atoms of
the mutant and wild-type structures is 0.39 Å over the entire
model and 0.28 Å for residues 52-62 of the loop. Deviations
of >1 Å appear among residues 63-70, 142, 143, and 267-
269, because of absent or weak electron density. A modest
level of electron density, however, covers Trp57 (Figure 2).
In fact, the indole group of Trp57 occupies the same space
as the side chain of Tyr57 in the wild-type T-state complex
(22). The indole moiety of Trp57 is in contact with Ile53
and Ile56 of its own subunit and Val196, Ile10, and Ile194
of an adjacent subunit (C1-C2 interface). Trp57 is more
exposed to solvent in the T-state (8.1 Å2 accessible surface
area to a 1.4 Å probe sphere) than in the R-state (6.4 Å2
accessible surface area). Higher B-parameters in the T-state
relative to those in the R-state suggest greater conformational
mobility for Trp57 in the T-state structure. Indeed, position
57 is in proximity to residues 63-70, which are disordered
completely and without electron density. The only difference
between wild-type and Trp57 FBPases in the T-state concerns
the binding of Zn2+. In the wild-type structure, there is only
one metal ion bound (at site 1), whereas in the mutant
Table 1: Kinetic Parameters for Wild-Type and Tyr57 f Trp FBPases
activity
ratio
(pH 7.5/pH 9.5)
kcat
(s-1)
Km-F16P2
(íM)
Ka-Mg2+
(mM2)
Hill coefficient
with Mg2+
Ki-F26P2
(íM)
I50-AMPa
(íM) K+ activationb
wild-type 3.3 22.0 ( 0.1 1.75 ( 0.08 0.67 ( 0.04 1.9 ( 0.1 0.264 ( 0.005 1.61 ( 0.05 16.8 ( 0.3
Trp57 mutant 3.3 24.0 ( 0.07 3.39 ( 0.09 0.53 ( 0.06 1.9 ( 0.1 0.84 ( 0.05 8.5 ( 0.4 16.6 ( 0.4
a The Hill coefficient of AMP inhibition is 2.0, as determined from a plot of Mg2+ concentration vs AMP concentration at a concentration of 20
íM F16P2. b Percent increase in initial velocity in the presence of Mg2+ (5Ka) and F16P2 (5Km), caused by the addition of KCl (150 mM).
Table 2: Statistics of Data Collection and Refinement for Trp57
Complexes
R-state T-state
ligands bound F6P, Pi, Zn2+ F6P, Pi, Zn2+, AMP
resolution (Å) 2.5 2.5
no. of measurements 38291 79656
no. of unique reflections 11308 25328
completeness of data (%)
data set 88 90
last shell (2.7-2.5 Å) 74 83
Rsyma 5.00 6.86
no. of reflections in refinementb 9914 23834
no. of atoms 2646 5153
no. of solvent sites 111 175
R-factorc 0.178 0.192
Rfreed 0.259 0.272
mean B (Å2) 22 32
root-mean-square deviations
bond lengths (Å) 0.009 0.008
bond angles (deg) 1.56 1.23
dihedral angles (deg) 24.7 24.8
improper dihedral angles (deg) 1.34 1.23
a Rsym ) “j“ijIij - 〈Ij〉j/“i“jIij, where i runs over multiple observations
of the same intensity and j runs over crystallographically unique
intensities. b All data in the resolution range of 5-2.5 Å. c R-factor )
“jjFobsj - jFcalcjj/“jFobsj, where jFobsj > 0. d R-factor based upon 10%
of the data randomly culled and not used in the refinement.
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structure, in addition to the metal at site 1, electron density
appears at site 2, which is consistent with a Zn2+ cation at
<40% occupancy or a water molecule.
Steady-State Fluorescence from the Trp57 Mutant. Ligands,
alone or in combination, do not influence the fluorescence
emission from a 100 íM tryptophan solution. In addition,
the metal site proximal to Trp57 in the R- and T-states is 15
and 23 Å away, respectively. These distances exclude most
quenching mechanisms except resonance energy transfer and
electron transfer. Resonance energy transfer is not possible,
simply because Mg2+, Zn2+, and Mn2+ do not absorb in the
range of fluorescence emission from tryptophan. Electron
transfer between the excited-state tryptophan and Mn2+ is
possible, but is not reflected in the experimental data. The
emission spectra of product complexes with Mn2+ and Zn2+
are equal in intensity, whereas that of Mg2+ is relatively low
(see below). Electron transfer between Mn2+ and Trp57,
however, should reduce the emission intensity from the
Mn2+-product complex relative to that from Mg2+ or Zn2+
complexes. Similarly, resonance energy transfer between
bound AMP and Trp57 is not possible, because AMP does
not absorb in the range of fluorescence emission of tryp-
tophan. Recorded differences in fluorescence emission, then,
must come from ligand-induced conformational changes,
which alter the environment of Trp57.
All changes in fluorescence emission reported here are
relative to the emission from the Trp57 mutant in the absence
of ligands and divalent metal cations. The emission spectrum
from the Trp57 mutant in the presence of Zn2+ (50 íM),
F6P (5 mM), Pi (5 mM), and saturating AMP (400 íM) has
a ìmax of 340 nm and a fluorescence intensity approximately
equal to that of the ligand-free enzyme (Figure 3 and Table
3). In the absence of AMP, the level of fluorescence emission
increases by 69% and ìmax shifts to 350 nm. The emission
spectrum ìmax from the Trp57 mutant in the presence of
F26P2 (240 íM), with or without Zn2+, F6P, and Pi, is 15%
higher than that from the Zn2+-product-AMP complex,
with a ìmax of 342 nm. The addition of F26P2 to the Zn2+-
product-AMP complex, however, causes no detectable
change in fluorescence emission (data not shown).
The emission spectra in the presence of F6P (5 mM), Pi
(5 mM), and AMP (400 íM) with Mg2+ (5 mM) or Mn2+
(0.5 mM) are identical to that of the Zn2+-product-AMP
complex (Figure 3 and Table 3). In the absence of AMP
and in the presence of products, however, Mg2+ causes a
much smaller increase in the level of fluorescence emission
(23%) and a smaller shift in ìmax to 346 nm than does either
Zn2+ or Mn2+. The addition of K+ (as KCl), at levels (150
mM) sufficient to saturate the monovalent cation site, caused
no change in fluorescence emission. The emission spectrum
in the presence of products, F26P2 and Mg2+, however, is
nearly identical to that of the corresponding complex with
Zn2+. The level of fluorescence emission from the Trp57
mutant in the presence of products, F26P2 and Mn2+, is 46%
higher than that of the metal-product-AMP complexes,
compared to 15% and 11% increases, respectively, when
Zn2+ and Mg2+ are used.
The change in fluorescence from the Zn2+-product
complex in response to the titration of AMP establishes a
Kd for AMP of 16 íM and a Hill coefficient of 2.1 (Figure
4). These values are very close to the I50-AMP (22 íM) and
FIGURE 1: Structure of the Trp57 mutant in the R-state. Displayed
is a stereoview of electron density from a 2Fobs - Fcalc map
associated with Trp57 at a contour level of 1ó (top) and an
illustration of two subunits (labeled C3 and C4) of FBPase (bottom).
Helices H1-H3 are represented as cylinders in both subunits,
whereas loop 52-72 (engaged conformer, bold line) and Trp57,
F6P, and Pi (ball-and-stick models) are presented only for subunit
C4. The bottom image was drawn with MOLSCRIPT (50).
FIGURE 2: Structure of the Trp57 mutant in the T-state. Displayed
is a stereoview of electron density from a 2Fobs - Fcalc map
associated with Trp57 at a contour level of 1ó (top) and an
illustration of two subunits (labeled C3 and C4) of FBPase (bottom).
Helices H1-H3 are represented as cylinders in both subunits,
whereas loop 52-72 (disengaged conformer, bold line) and Trp57,
F6P, Pi, and AMP (ball-and-stick models) are presented only for
subunit C4. The bottom image was drawn with MOLSCRIPT (50).
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Hill coefficient (2.0) determined by kinetics at saturating
Mg2+ concentrations (5 mM).
DISCUSSION
The mutation of Tyr57 to tryptophan results in only minor
changes in the functional and structural properties of FBPase.
Crystal structures of the Zn2+-product complex of the Trp57
mutant in the presence and absence of AMP are virtually
identical to those of the wild-type enzyme under the same
crystallization conditions. Using Mg2+ as the cation activator,
many of the functional properties of FBPase (pH 7.5/pH 9.5
activity ratio, kcat, Km for F16P2, potassium activation, and
Hill coefficients for Mg2+ and AMP) are indistinguishable
from those of the wild-type enzyme. The 4- and 5-fold
increases in Ki values for F26P2 and AMP, respectively, do
indicate a mutation-dependent change in functional proper-
ties; however, the elevated Ki values probably result from
the enhanced stability of the R-state relative to the T-state
of the mutant. Elevated Ki values for both AMP and F26P2
are consistent with the model of Choe et al. (19), which
requires AMP-bound and F26P2-bound states of FBPase to
have disengaged loops. Any mutation, which stabilizes an
engaged loop 52-72, should increase the Ki values of AMP
and F26P2. Under extremes in ligand concentration (AMP
absent and AMP saturating) and the presence of Zn2+-
product complexes, the Trp57 mutant adopts the R- and
T-state conformations of the wild-type enzyme. Furthermore,
initial velocity assays indicate no change in the kinetic
mechanisms of inhibition by AMP (competitive with respect
to Mg2+ and noncompetitive with respect to F26P2) and
F26P2 (competitive with respect to F16P2). Evidently,
tryptophan at position 57 is a nonperturbing spectroscopic
probe of enzyme function and conformation.
Common quenchers of tryptophan fluorescence are water,
the peptide bond, and specific amino acid side chains (35).
The indole group of Trp57 in the T-state is neither close to
a side chain particularly effective as a quencher, nor does
its exposure to solvent differ significantly from that in the
R-state (8.1 vs 6.4 Å2). FBPase, however, is not a static
structure. Thermal parameters are an approximate measure
of conformational dynamics, and on the basis of such
parameters, the indole of Trp57 undergoes greater confor-
mational movement in the T-state than in the R-state. We
may observe electron density for only the most solvent
inaccessible conformer for Trp57 in the T-state. Other
conformers would convolute the electron density of Trp57
with that of the solvent, resulting in a uniform carpet of
electron density, indistinguishable from noise. The wave-
FIGURE 3: Fluorescence spectra of the Trp57 mutant under different ligation conditions. (A) Enzyme under R-state conditions of ligation
(5 mM F6P and 5 mM KPi) in the presence of 50 íM Zn2+ (bold line), 0.5 mM Mn2+ (asterisks), 5 mM Mg2+ (open circles), and no metal
(solid line). (B) Enzyme under T-state conditions of ligation (5 mM F6P, 5 mM KPi, and 0.4 mM AMP) in the presence of 50 íM Zn2+
(bold line), 0.5 mM Mn2+ (asterisks), 5 mM Mg2+ (open circles), and no metal (solid line). (C) Enzyme in the presence of F26P2 (240 íM)
and products (5 mM F6P and 5 mM KPi) in the presence of 50 íM Zn2+ (bold line), 0.5 mM Mn2+ (asterisks), 5 mM Mg2+ (open circles),
and no metal (solid line).
Table 3: Fluorescence Emission from Ligated Complexes of Trp57
FBPase
5 mM F6P
and KPi
5 mM F6P and KPi
with 400 íM AMP
5 mM F6P and KPi
with 240 íM F26P2
divalent cation Fa
ìmax
(nm) Fa
ìmax
(nm) Fa
ìmax
(nm)
none 1.00 340 1.00 340 1.00 340
Zn2+ (50 íM) 1.69 350 0.96 340 1.15 342
Mg2+ (5 mM) 1.23 346 0.96 342 1.11 340
Mn2+ (0.5 mM) 1.59 350 1.00 340 1.46 348
a Relative fluorescence emission at ìmax from the Trp57 mutant
without divalent cations in the presence of F6P (5 mM) and KPi (5
mM).
FIGURE 4: AMP titration of the Trp57 mutant as monitored by
fluorescence emission. The enzyme is in 5 mM F6P, 5 mM Pi, and
50 íM Zn2+. AMP is added up to a final concentration of 0.2 mM.
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length of maximum fluorescence emission for tryptophan
(ìmax) in water is 352 nm and decreases in more hydrophobic
environments (36). The observed ìmax for Trp57 in the T-state
is approximately 340 nm, which is consistent with a mixture
of solvent-exposed and hydrophobic environments for the
indole group.
Trp57 in the R-state occupies a pocket lined primarily with
hydrophobic side chains. The thermal parameters for the
indole moiety in the R-state reflect a fully occupied confor-
mational state, with moderate conformational movement. The
ìmax for an indole under such circumstances should be blue-
shifted relative to tryptophan in solution, but ìmax occurs at
approximately 350 nm. This anomalous behavior of the
indole group in the R-state may arise from its specific
electrostatic environment, which may be dominated by the
negative charge of Asp127 (Figures 1 and 5). The difference
dipole vector, determined from the dipole moments of the
ground and excited (1La) states of indole, lies in the plane of
the fused ring and is directed approximately as shown in
Figure 5. The electrostatic field caused by Asp127 will
decrease the energy separation between the ground and
excited states. That decrease is consistent with the 10 nm
red shift in the R-state spectrum relative to the T-state
spectrum.
The environment of Trp57 in the R-state may influence
fluorescence emission by other mechanisms as well. Al-
though the imino group of the indole ring does not make a
hydrogen bond in the crystal structure, backbone carbonyl
126 and the side chain of Asp127 need move by no more
than 1 Å to hydrogen bond with the indole group. Hydrogen
bonding with the indole would contribute to the observed
red shift, noted above. Additionally, several surrounding side
chains are effective quenchers of fluorescence (35). Asp127,
His253, Cys183, and Tyr258 are 3.4, 6.8, 7.1, and 7.5 Å,
respectively, from the indole moiety in the R-state. In the
absence of one or several of these side chains, the level of
fluorescence emission from Trp57 could increase signifi-
cantly.
A two-state system (disengaged loop, T-state and engaged
loop, R-state) cannot account for the variation in fluorescence
spectra observed in the study presented here. First, the Trp57
mutant, in the absence of metal activators and other ligands,
has a disengaged loop, as evidenced by its low level of
fluorescence emission. In fact, the fluorescence spectrum in
the absence of all ligands is nearly indistinguishable from
spectra of metal-product-AMP complexes (Figure 3). On
the basis of CD spectroscopy, however, the Trp57 mutant,
in the absence of ligands, is in the R-state. Evidently, the
fluorescence spectrum of the Trp57 mutant is not sensitive
to the quaternary conformation of FBPase (T- or R-state),
as is CD spectroscopy, but is instead sensitive to the
conformational state of loop 52-72 (engaged or disengaged).
Work of Lipscomb and colleagues has revealed R-state,
disengaged loop conformers of wild-type FBPase under a
number of crystallization conditions (37-39). Hence, an
R-state, disengaged loop conformer for FBPase is probably
a well-populated state for the enzyme in solution.
Variations in fluorescence emission levels of metal-
product complexes could reflect differences in the equilib-
rium populations of R-state conformers (engaged vs disen-
gaged loop). If so, then Mg2+ would be the least effective
of the divalent cations in stabilizing the R-state, engaged
conformation of FBPase. Indeed, of the divalent cation
activators, Mg2+ binds to FBPase with much lower affinity
than either Mn2+ or Zn2+, and its level of fluorescence
emission is significantly lower than that of Mn2+ or Zn2+.
Although attractive for its simplicity, the above explanation
for the low level of fluorescence emission from the Mg2+-
product complex is difficult to reconcile with the absence
of a K+-induced increase in the level of fluorescence
emission. K+ putatively binds to or near metal site 3, which
is unoccupied by Mg2+ at a concentration of 5 mM (22).
Directed mutations of loop residues, which weaken Mg2+
association, also abolish K+ activation (21). Hence, if the
low level of fluorescence emission observed from the Mg2+-
product complex is due to an equilibrium mixture of engaged
and disengaged conformers, then the addition of K+ should
stabilize the engaged loop and thereby enhance fluorescence
emission. Such is not the case. Evidently, if K+ does bind
to metal site 3, it does not influence the time-averaged
environment of Trp57. The low level of fluorescence
emission from the Mg2+-product complex then may reflect
a different conformational state for FBPase (see below).
On the basis of difference spectroscopy, AMP and F26P2
stabilize the same conformation of FBPase (40), presumably
a T-state, disengaged loop conformation. Fluorescence emis-
sion spectra from the Trp57 mutant in the presence of
saturating F26P2 or saturating AMP, however, are not
identical. The time-averaged environment of Trp57 is prob-
ably less solvent accessible in metal-F26P2 complexes, than
in metal-AMP complexes. Conceivably, metal-F26P2
complexes may be an equilibrium mixture of loop-engaged
and disengaged conformers. If so, then Mn2+ must stabilize
more of the metal-F26P2 complex in the engaged loop
conformation, than either Zn2+ or Mg2+. Indeed, F26P2 is
almost 50-fold less effective as an inhibitor of FBPase when
assayed with Mn2+ than with either Mg2+ or Zn2+ (41).
Alternatively, the conformation of metal-F26P2 complexes
of the Trp57 mutant may represent distinct conformational
states of loop 52-72, rather than an equilibrium mixture of
FIGURE 5: Schematic of the electrostatic perturbation due to Asp127
on the fluorescence emission energy from Trp57. The difference
dipole moment ¢í is the dipole moment of ground-state indole
subtracted from the dipole moment of the 1La excited state. Its
orientation here is based on information provided by Callis (51).
The change in energy between ground and excited states due to a
point negative charge positioned between the oxygen atoms of the
side chain of Asp127 is -¢í  E. Given the geometrical
relationship of Asp127 to Trp57, the electrostatic perturbation
decreases the separation in ground state and 1La energy levels,
causing a red shift in the fluorescence emission.
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engaged and disengaged loops. Available crystal structures
of F26P2 complexes of FBPase may not be faithful repre-
sentations of metal-F26P2 complexes, because of the
degradation of F26P2 to F6P on one hand (42, 43) and the
inclusion of AMP on the other (17, 44). As the emission
spectra of metal-product-F26P2-AMP and metal-product-
AMP complexes are identical, AMP evidently stabilizes the
same T-state, disengaged loop conformation to the exclusion
of all other conformers.
Fluorescence spectra of the Trp57 mutant are clearly
consistent with a dynamic loop, sensitive to cation activators
and specific ligands. The crystallographic structures (R-state,
engaged loop; R-state, disengaged loop; and T-state, disen-
gaged loop), however, may represent only some of the well-
populated conformational states of FBPase in solution.
Cation-dependent differences in fluorescence emission from
the Trp57 mutant are real and are in harmony with reports
of differing kinetic mechanisms and anomeric specificity with
Mg2+ and Mn2+ (1, 45-47). As a consequence of the
symmetry inherent in crystal structures, FBPase has been
represented in solution as a tetramer, which retains three
intersecting axes of symmetry. Reports are in the literature,
however, regarding half-of-sites reactivity and pairwise
association of AMP (48, 49), which necessarily requires the
loss of at least one symmetry axis of the tetramer. These
asymmetric conformers of FBPase may account for the
variety of conformational states inferred by fluorescence
spectroscopy.
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